# CXCL2

## Overview
CXCL2 is a gene that encodes the protein C-X-C motif chemokine ligand 2, also known as macrophage inflammatory protein-2 (MIP-2). This chemokine is a critical component of the immune system, primarily involved in the recruitment and activation of neutrophils, a type of white blood cell essential for the body's defense against infections and in the inflammatory response. CXCL2 functions as a high-affinity ligand for the CXCR2 receptor, facilitating neutrophil chemotaxis and activation, which are vital processes in both innate immunity and tissue homeostasis (Kolaczkowska2013Neutrophil; Zenobia2013Commensal). The protein is active in the extracellular space, where it interacts with endothelial cells and glycosaminoglycans to form chemokine gradients necessary for effective immune cell recruitment (Sawant2020Neutrophil). CXCL2's role extends beyond normal physiological processes, as its dysregulation is implicated in various pathological conditions, including cancer and inflammatory diseases, making it a potential target for therapeutic interventions (Zhou2023The).

## Function
CXCL2, also known as macrophage inflammatory protein-2 (MIP-2), is a chemokine that plays a significant role in the immune response by recruiting neutrophils to sites of inflammation. It functions as a high-affinity agonist for the CXCR2 receptor, which is crucial for neutrophil chemotaxis and activation (Kolaczkowska2013Neutrophil). In healthy human cells, CXCL2 is involved in maintaining tissue homeostasis, particularly in periodontal tissues, by regulating neutrophil migration to the junctional epithelium. This process is essential for innate immune defense and is influenced by commensal bacterial colonization, which modulates CXCL2 expression through the MyD88 signaling pathway (Zenobia2013Commensal).

CXCL2 is also implicated in the broader context of inflammation, where it provides a powerful signal for neutrophil emigration following initial priming by other chemokines. This sequential recruitment process is vital for effective immune responses during inflammation (Kolaczkowska2013Neutrophil). The chemokine is active in the extracellular space, where it interacts with endothelial cells to facilitate neutrophil adhesion and transmigration, contributing to wound healing and infection defense (Kolaczkowska2013Neutrophil).

## Clinical Significance
Alterations in the expression of the CXCL2 gene are associated with various diseases, particularly cancers. In colorectal cancer (CRC), CXCL2 is overexpressed, contributing to tumor proliferation, migration, and angiogenesis, and is linked to poor overall survival in patients (Omran2024Decoding; Zhou2023The). Similarly, in pancreatic adenocarcinoma (PAAD), CXCL2 is upregulated and promotes tumor angiogenesis through interactions with its receptor CXCR2, making it a potential therapeutic target (Huang2021Prognostic).

In ovarian cancer, CXCL2 overexpression correlates with poor prognosis, indicating its significant role in the disease's progression (Zhou2023The). In hepatocellular carcinoma (HCC), CXCL2 acts as a tumor suppressor by inhibiting ERK1/2 signaling pathways and promoting apoptosis, although it also contributes to an immunosuppressive microenvironment by recruiting neutrophils (Zhou2023The).

Beyond cancer, CXCL2 is involved in inflammatory diseases. It plays a role in acute liver injury by recruiting neutrophils, which contribute to liver damage (Zhou2023The). In nonalcoholic steatohepatitis (NASH), CXCL2 is a key gene associated with inflammation development through immune cell recruitment (Zhou2023The). These findings highlight CXCL2's potential as a biomarker and therapeutic target in various diseases.

## Interactions
CXCL2, also known as macrophage inflammatory protein-2 (MIP-2), primarily interacts with the CXCR2 receptor, playing a crucial role in neutrophil recruitment and activation. This interaction is characterized by CXCL2's ability to bind to CXCR2 with high affinity, which is essential for triggering signaling pathways mediated by G-proteins and β-arrestin, leading to neutrophil trafficking and activation (Rajarathnam2019How; Sawant2020Neutrophil). CXCL2 exists in both monomeric and dimeric forms, with the dimer form exhibiting higher activity in terms of G protein and β-arrestin activities (Sawant2020Neutrophil).

CXCL2 also interacts with glycosaminoglycans (GAGs) such as heparan sulfate (HS), which is crucial for the formation of stable chemokine gradients necessary for effective neutrophil recruitment. The dimer form of CXCL2 has a higher affinity for GAGs compared to the monomer, which influences its recruitment activity (van2018Differential; Sawant2020Neutrophil). These interactions with GAGs are significant as they affect chemokine function, including presentation for CXCR2 binding and transport to the vasculature (Sawant2020Neutrophil). The binding of CXCL2 to specific HS domains is dose-dependent and is influenced by the sulfation patterns of these domains (van2018Differential).


## References


[1. (Zenobia2013Commensal) Camille Zenobia, Xiao Long Luo, Ahmed Hashim, Toshiharu Abe, Lijian Jin, Yucheng Chang, Zhi Chao Jin, Jian Xun Sun, George Hajishengallis, Mike A. Curtis, and Richard P. Darveau. Commensal bacteria-dependent select expression of cxcl2 contributes to periodontal tissue homeostasis: bacterial contributions to neutrophil homing in healthy gingival tissues. Cellular Microbiology, 15(8):1419–1426, March 2013. URL: http://dx.doi.org/10.1111/cmi.12127, doi:10.1111/cmi.12127. This article has 90 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cmi.12127)

[2. (Sawant2020Neutrophil) Kirti V Sawant, Krishna Mohan Sepuru, Emily Lowry, Brigith Penaranda, Charles W Frevert, Roberto P Garofalo, and Krishna Rajarathnam. Neutrophil recruitment by chemokines cxcl1/kc and cxcl2/mip2: role of cxcr2 activation and glycosaminoglycan interactions. Journal of Leukocyte Biology, 109(4):777–791, September 2020. URL: http://dx.doi.org/10.1002/jlb.3a0820-207r, doi:10.1002/jlb.3a0820-207r. This article has 69 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jlb.3a0820-207r)

[3. (Huang2021Prognostic) Jiacheng Huang, Zhitao Chen, Chenchen Ding, Shengzhang Lin, Dalong Wan, and Kuiwu Ren. Prognostic biomarkers and immunotherapeutic targets among cxc chemokines in pancreatic adenocarcinoma. Frontiers in Oncology, August 2021. URL: http://dx.doi.org/10.3389/fonc.2021.711402, doi:10.3389/fonc.2021.711402. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2021.711402)

[4. (van2018Differential) J. J. van Gemst, M. Kouwenberg, A. L. W. M. M. Rops, T. H. van Kuppevelt, J. H. Berden, T. J. Rabelink, M. A. Loeven, and J. van der Vlag. Differential binding of chemokines cxcl1, cxcl2 and ccl2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains. PLOS ONE, 13(9):e0201560, September 2018. URL: http://dx.doi.org/10.1371/journal.pone.0201560, doi:10.1371/journal.pone.0201560. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0201560)

[5. (Kolaczkowska2013Neutrophil) Elzbieta Kolaczkowska and Paul Kubes. Neutrophil recruitment and function in health and inflammation. Nature Reviews Immunology, 13(3):159–175, February 2013. URL: http://dx.doi.org/10.1038/nri3399, doi:10.1038/nri3399. This article has 3857 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nri3399)

[6. (Rajarathnam2019How) Krishna Rajarathnam, Michael Schnoor, Ricardo M. Richardson, and Sudarshan Rajagopal. How do chemokines navigate neutrophils to the target site: dissecting the structural mechanisms and signaling pathways. Cellular Signalling, 54:69–80, February 2019. URL: http://dx.doi.org/10.1016/j.cellsig.2018.11.004, doi:10.1016/j.cellsig.2018.11.004. This article has 166 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2018.11.004)

[7. (Omran2024Decoding) Thura Akrem Omran, Hege Smith Tunsjø, David Jahanlu, Stephan Andreas Brackmann, Vahid Bemanian, and Per Christian Sæther. Decoding immune-related gene-signatures in colorectal neoplasia. Frontiers in Immunology, June 2024. URL: http://dx.doi.org/10.3389/fimmu.2024.1407995, doi:10.3389/fimmu.2024.1407995. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2024.1407995)

[8. (Zhou2023The) Chenjia Zhou, Ying Gao, Peilun Ding, Tao Wu, and Guang Ji. The role of cxcl family members in different diseases. Cell Death Discovery, July 2023. URL: http://dx.doi.org/10.1038/s41420-023-01524-9, doi:10.1038/s41420-023-01524-9. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41420-023-01524-9)